Press release
Generic Injectables Market Forecast 2024-2033 - Major Trends, Segments And Fastest Growing Regions | Baxter International Inc., Sanofi SA, AstraZeneca plc., Fresenius Medical Care AG & Co. KGaA
Generic Injectables Global Market Report
The Business Research Company offers in-depth market insights through Generic Injectables Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The generic injectables market size has grown rapidly in recent years. It will grow from $109.42 billion in 2023 to $125.97 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to cost-effectiveness, patent expirations, healthcare access initiatives, market competition, global pharmaceutical trends..
The generic injectables market size is expected to see rapid growth in the next few years. It will grow to $209.47 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to increasing aging population, strategic alliances, regulatory changes, rising healthcare awareness, market innovation.. Major trends in the forecast period include focus on quality and regulatory compliance, adoption of the 505(b)(2) regulatory pathway, development of novel drug delivery technologies, collaborations and partnerships in the industry, increased focus on specialty injectable therapies..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10776&type=smp
Market Segmentation:
The generic injectables market covered in this report is segmented -
1) By Product Type: Monoclonal Antibodies, Cytokines, Insulin, Vaccines, Other Products
2) By Container Type: Vials, Ampoules, Premix, Prefilled Syringes, Other Containers
3) By Route Of Administration: Intravenous, Intramuscular, Subcutaneous, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Prescription Stores
5) By Application: Oncology, Diabetes , Infectious Diseases , Blood Disorders , Musculoskeletal Disorders , Hormonal Disorders , Pain Management , CNS Diseases , Cardiovascular Diseases
Major Driver - Impact Of Increasing Cancer And Cardiovascular Disease Prevalence On The Growth Of The Generic Injectable Market
The rising prevalence of cancer and cardiovascular diseases is expected to propel the growth of the generic injectable market going forward. Cardiovascular diseases refer to a group of disorders of the heart and blood vessels, and cancer is a disease in which some of the body's cells grow uncontrollably and spread to other parts of the body. Generic injectables are used in cancer and cardiac diseases to offer similar pharmaceutical equivalence or bioequivalence to brand-drugs and enhanced drug availability and accessibility to provide more affordable treatment. For instance, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by noncommunicable diseases (NCDs) or chronic diseases every year globally were 17.9 million deaths are from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths are from diabetes. Therefore, the rising prevalence of cancer and cardiovascular diseases is driving the growth of the generic injectable market.
Competitive Landscape:
Major companies operating in the generic injectables market report are Baxter International Inc., Sanofi SA, AstraZeneca plc., Fresenius Medical Care AG & Co. KGaA, Johnson & Johnson, Merck & Co. Inc., Biocon Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Samsung Biologics Co. Ltd., Piramal Pharma Limited, Amgen Inc., Bristol-Myers Squibb Company, Pfizer Inc., Hikma Pharmaceuticals PLC, Par Pharmaceutical, Pharmascience Inc., SAGENT Pharmaceuticals, AmerisourceBergen Corporation, Hospira Inc., Sandoz International GmbH, Singota Solutions Inc., MVASI Bevacizumab-awwb Syringes, Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Endo International plc, Akorn Pharmaceuticals Inc., Wockhardt Limited
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/generic-injectables-global-market-report
Top Trend - Product Innovations Driving Growth In The Generic Injectables Market
Product innovations are a key trend gaining popularity in the generic injectables market. Major companies operating in the generic injectables market are advancing generic injectables to sustain their position in the market. For instance, in April 2022, Dr. Reddy's Laboratories, an India-based pharmaceutical company, launched Treprostinil Injection in the U.S. market. This drug is a therapeutic equivalent generic version of Remodulin (treprostinil) Injection approved by the U. S. Food and Drug Administration (USFDA), a US-based agency. This drug is applicable for patients requiring a transition from epoprostenol to reduce the rate of clinical deterioration.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Generic Injectables Market Characteristics
3. Generic Injectables Market Trends And Strategies
4. Generic Injectables Market - Macro Economic Scenario
5. Generic Injectables Market Size And Growth
…..
27. Generic Injectables Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Injectables Market Forecast 2024-2033 - Major Trends, Segments And Fastest Growing Regions | Baxter International Inc., Sanofi SA, AstraZeneca plc., Fresenius Medical Care AG & Co. KGaA here
News-ID: 3391139 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
